用户名: 密码: 验证码:
木瓜苷和儿茶素对小鼠细胞免疫功能的调节作用
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:
     T细胞介导的细胞免疫应答在移植物排斥、移植物抗宿主反应、自身免疫和肿瘤免疫等方面起重要作用。小鼠迟发型超敏反应(delayed-type hypersensitivity,DTH)是由特异性致敏效应T细胞介导的细胞免疫反应。本实验采用2,4-二硝基氯苯(2,4-dinitrochlorobenzene,DNCB)诱导的小鼠DTH反应以及环磷酰胺(cyclophosphamide,Cy)增强或抑制DNCB诱导的小鼠DTH反应作为细胞免疫功能异常的模型,从整体、胸腺T细胞增殖以及胸腺T细胞产生的细胞因子等方面观察木瓜苷(glucosides of Chaenomeles speciosa,GCS)和儿茶素(catechin,Cat)对上述各模型的影响,研究GCS和Cat对细胞免疫的调节作用及其部分机制,并探讨Cat是否是GCS发挥作用的主要有效成份之一。
     方法:
     以DNCB诱导小鼠DTH反应,于DNCB致敏前3天腹腔注射(intragperitoneal injection,ip)Cy(250 mg·kg~(-1))和致敏后立即ip Cy(125 mg·kg~(-1))分别诱导小鼠增强和抑制的DTH反应;于致敏前3天GCS(60,120,240 mg·kg~(-1)·d~(-1))和Cat(30,60,120 mg·kg~(-1)·d~(-1))灌胃给药(intragastric administration,ig)(d_(-3)~d_4),连续7d。用耳肿胀度、胸腺和脾指数作为整体检测指标;以ConA诱导胸腺T淋巴细胞,观察不同剂量或浓度的GCS和Cat体内外对胸腺T淋巴细胞增殖及其产生的细胞因子IL-2、IL-4的影响。MTT法检测胸腺T淋巴细胞增殖,ConA诱导的胸腺T淋巴细胞培养上清中IL-2活性检测采用活化的小鼠胸腺细胞MTT比色法;ELISA法测定小鼠胸腺T淋巴细胞培养上清中IL-4水平。
     结果:
     1.GCS和Cat对正常DTH小鼠细胞免疫功能的影响GCS和Cat对正常小鼠DTH有明显的抑制作用。GCS(60,120,240 mg·kg~(-1)),Cat(120 mg·kg~(-1))能显著下调DTH小鼠的耳肿胀;GCS(120,240 mg·kg~(-1))和Cat(120 mg·kg~(-1))可显著下调DTH小鼠的胸腺及脾脏指数;GCS(60,120,240 mg·kg~(-1)),Cat(60,120 mg·kg~(-1))可显著下调DTH小鼠胸腺T淋巴细胞增殖反应以及产生IL-2的水平,使之接近正常水平。GCS(120,240 mg·kg~(-1))和Ca(t120 mg·kg~(-1))可显著上调DTH小鼠降低的胸腺T淋巴细胞产生IL-4的水平。
     体外实验进一步证实,GCS(12.5~200μg·ml~(-1))及Cat(25~200μg·ml~(-1))能显著下调DTH小鼠胸腺T淋巴细胞增殖反应和产生IL-2的水平,GCS(25~200μg·ml~(-1))及Cat(50~200μg·ml~(-1))能显著上调DTH小鼠胸腺T淋巴细胞产生IL-4的水平。
     2. GCS和Cat对Cy增强的DTH小鼠细胞免疫功能的影响
     GCS和Cat对Cy增强的小鼠DTH有明显的抑制作用。GCS(60,120,240 mg·kg~(-1))和Cat(120 mg·kg~(-1))能显著下调Cy增强的DTH小鼠耳肿胀度;GCS(120,240 mg·kg~(-1))和Cat(120 mg·kg~(-1))能显著下调Cy增强的DTH小鼠胸腺指数;GCS(60,120,240 mg·kg~(-1))和Cat(60,120 mg·kg~(-1))可显著下调Cy增强的DTH小鼠脾指数;GCS(120,240 mg·kg~(-1))和Cat(60,120 mg·kg~(-1))可显著下调Cy增强的DTH小鼠胸腺T淋巴细胞增殖反应;GCS(60,120,240 mg·kg~(-1))及Cat(30,60,120 mg·kg~(-1))能显著下调Cy增强的DTH小鼠胸腺T淋巴细胞产生IL-2的水平;GCS(120,240 mg·kg~(-1))及Cat(120 mg·kg~(-1))能显著上调Cy增强的DTH小鼠胸腺T淋巴细胞产生IL-4的水平。
     体外实验进一步证实,GCS(12.5~200μg·ml~(-1))及Cat(25~200μg·ml~(-1))能显著下调Cy增强的DTH小鼠胸腺T淋巴细胞增殖反应和产生IL-2的水平,GCS(25~200μg·ml~(-1))及Cat(50~200μg·ml~(-1))能显著上调Cy增强的DTH小鼠胸腺T淋巴细胞产生IL-4的水平。
     3. GCS和Cat对Cy抑制的DTH小鼠细胞免疫功能的影响
     GCS和Cat对受抑制的小鼠细胞免疫功能有增强作用。GCS(120,240 mg·kg~(-1))及Cat(60,120 mg·kg~(-1))能显著上调Cy抑制小鼠的耳肿胀度;GCS(60,120,240 mg·kg~(-1))及Cat(60,120 mg·kg~(-1))能显著上调Cy抑制小鼠胸腺指数和脾指数;GCS(60,120,240 mg·kg~(-1))及Cat(60,120 mg·kg~(-1))能显著上调Cy抑制小鼠胸腺T淋巴细胞增殖以及产生IL-2和IL-4的水平。
     体外实验进一步证实,GCS(12.5~200μg·ml~(-1))及Cat(25~200μg·ml~(-1))能显著上调Cy抑制DTH小鼠胸腺T淋巴细胞增殖反应和产生的IL-4水平;GCS (12.5~200μg·ml~(-1))及Cat(12.5~200μg·ml~(-1))能显著上调Cy抑制的DTH小鼠胸腺T淋巴细胞产生的IL-2水平。.
     结论:
     GCS和Cat对免疫功能异常的小鼠的细胞免疫具有机能依赖性的双向免疫调节作用,其作用机制可能与调节小鼠胸腺T淋巴细胞增殖及其产生的细胞因子水平,恢复Th1(IL-2)与Th2(IL-4)之间以及Th与Ts之间的平衡有关。GCS是木瓜调节小鼠细胞免疫的有效部位,Cat可能是GCS调节细胞免疫的有效成分之一。
Aim: T-cells Play an important role in transplant rejection, graft-versus-host reaction, autoimmune and tumor immunity. Delayed-type hypersensitivity (DTH) in mice is a specific T cell-mediated immune response.To confirm whether glucosides of Chaenomeles speciosa (GCS) and catechins (Cat) can regulate cell immunity of mice, and to explore whether Cat is one of the main active ingredient of GCS, the study used DTH induced by 2, 4-dinitrochlorobenzene (DNCB) and cyclophosphamide (Cy) potentiated or suppressed DTH in mice as a model of immune dysfunction to observe the impact of GCS and Cat on the above-mentioned model from the level of the whole, the thymocytes proliferation and cytokines produced by thymocytes.
     Methods: DTH of mice was induced by DNCB. The potentiated and suppressed DTH of mice was developed by Cy at a dose of 250 mg·kg~(-1) 3 days prior to the sensitization by DNCB and 125 mg·kg~(-1) simultaneously with the sensitization of the mice by DNCB respectively. GCS (60, 120, 240 mg·kg~(-1)) and Cat (30, 60, 120 mg·kg~(-1)) were given intragastrically (ig) 3 days prior to the sensitization once daily for 7 consecutive days. Ear swelling degree, thymus index and spleen index was used as evaluating indication. Thymus lymphocyte proliferation was induced by concanavalin A (ConA) to examine the influence of different doses or concentrations of GCS and Cat on the lymphocyte proliferation and secretion of interleukin-2 and interleukin-4 in vivo or vitro. ConA-induced thymocytes proliferation was measured by 3-(4,5-dimethylthiazol-2- -thiazolyl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay. IL-2 activity was measured by testing its ability to support ConA-induced mice thymocytes proliferation by the MTT assay. IL-4 were measured by enzyme-linked immunosorbent assay(ELISA).
     Results:
     1. the effects on cell immunity of DTH mice by GCS and Cat. GCS and Cat could significantly inhibite DTH response in Normal mice. GCS (60, 120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly decrease the ear swelling; GCS (120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly decrease the thymus index and the spleen index; GCS (60, 120, 240 mg·kg~(-1)) and Cat (60, 120 mg·kg~(-1)) could decrease thymocytes proliferation and IL-2 levels to close to the Normal levels; GCS (120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly increase IL-4 levels in cultures of thymocytes from DTH mice.
     In vitro, GCS (12.5~200μg·ml~(-1)) and Cat (25~200μg·ml~(-1)) could significantly decrease thymocytes proliferation and IL-2 levels. GCS (25~200μg·ml~(-1)) and Cat (50~200μg·ml~(-1)) could significantly increase IL-4 levels in cultures of thymocytes from DTH mice with a concentration-dependent dose-effect relationship.
     2. the effects on cell immunity of Cy- potentiated DTH mice by GCS and Cat. GCS and Cat could significantly inhibite DTH response in Cy-potentiated DTH mice. GCS (60, 120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly decrease the ear swelling of Cy-potentiated DTH mice; GCS (120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly decrease the thymus index of Cy-potentiated DTH mice; GCS (60, 120, 240 mg·kg~(-1)) and Cat (60, 120 mg·kg~(-1)) could significantly decrease the spleen index of Cy-potentiated DTH mice; GCS (120, 240 mg·kg~(-1)) and Cat(60, 120 mg·kg~(-1)) could significantly decrease thymocytes proliferation; GCS (60, 120, 240 mg·kg~(-1)) and Cat (30, 60, 120 mg·kg~(-1)) could significantly decrease the IL-2 levels in the culture supernatants of thymocytes; GCS (120, 240 mg·kg~(-1)) and Cat (120 mg·kg~(-1)) could significantly increase IL-4 levels in cultures of thymocytes from the Cy- potentiated DTH mice.
     In vitro, GCS (12.5~200μg·ml~(-1)) and Cat (25~200μg·ml~(-1)) could significantly decrease thymocytes proliferation and IL-2 production of thymocytes; GCS (25~200μg·ml~(-1)) and Cat (50~200μg·ml~(-1)) could increase IL-4 levels in cultures of thymocytes from the Cy- potentiated DTH mice.
     3. the effects on cell immunity of Cy-suppressed DTH mice by GCS and Cat.
     GCS and Cat could enhance DTH response in Cy-suppressed DTH mice. GCS (120, 240 mg·kg~(-1)) and Cat(60,120 mg·kg~(-1)) could significantly increase the ear swelling of Cy-suppressed DTH mice; GCS (60, 120, 240 mg·kg~(-1)) and Cat (60, 120 mg·kg~(-1)) could significantly increase thymus index, spleen index of the Cy- suppressed DTH mice; GCS (60, 120, 240 mg·kg~(-1)) and Cat (60, 120 mg·kg~(-1)) could significantly increase thymocytes proliferation, IL-2 and IL-4 levels in cultures of thymocytes from the Cy-suppressed DTH mice.
     In vitro, GCS (12.5~200μg·ml~(-1)) and Cat (25~200μg·ml~(-1)) could significantly increase thymocytes proliferation and IL-4 production of thymocytes; GCS (12.5~200μg·ml~(-1)) and Cat (12.5~200μg·ml~(-1)) could significantly increase IL-2 production of thymocytes.
     Conclusion: GCS and Cat might have dual immunomodulatory effects in a function dependent manner in mice with immune dysfunction by regulating functions of immune organ of mice, thymocytes proliferation and the level of cytokine production by thymocytes, and balancing Th1 (IL-2) and Th2 (IL-4), Th and Ts. GCS are active compound in regulating the cell immunity of mice, Cat might regulate cell immunity of mice as one of the active ingredients of GCS.
引文
1.张玲玲,魏伟.木瓜苷对小鼠胶原性关节炎的预防作用及初步机制.中国药理学通报,2004;20(1):95-100.
    2.陈群,魏伟.木瓜苷对Ⅱ型胶原性关节炎大鼠滑膜细胞G蛋白偶联信号转导的作用及其机制.中国药理通讯,2003;20(3):46-8.
    3.戴敏,魏伟,汪倪萍,陈群.木瓜苷对大鼠佐剂性关节炎的治疗作用.中国药理学通报,2003;19(3):340-4.
    4.陈尹,魏伟,吴虹,王晓玉,杨宇清.木瓜苷对佐剂性关节炎大鼠血清抗体水平的下调作用.中国药理学通报,2007;23(7):941-4.
    5.郑咏秋,魏伟,戴敏,汪倪萍.木瓜总苷抑制小鼠接触性超敏反应及对其胸腺T淋巴细胞亚型的调节作用.中国药理学通报,2004;20(9):1016-20.
    6.Zheng YQ , WEI W, Wang NP. Effects of Chaenomeles speciosa glucosides on cyclophosphamide potentiated contact hypersensitivity in mice. Chin J Pharmacol Toxicol, 2004; 18(6): 415-20.
    7.黄晴,吴立军,路平,田代真一,小野寺敏,池岛乔.儿茶素对tBHP诱导N9细胞DNA损伤的保护作用.中国药理学通报,2005;21(12):1520-3.
    8.Geetha T, Garg A, Chopra k, Pal Kaur I. Delineation of antimutagenic activity of catechin, epicatechin and green tea extract. Mutatres, 2004; 556(122): 65-74.
    9.冯星,许东晖,梅血婷,朱良,许实波.儿茶素和漆黄素对柠檬酸铁诱导大鼠原代肝细胞损伤的保护作用.中国药理学通报,2003;19(12):1397-401.
    10.张晓君,祝晨,胡黎,等.党参多糖对小鼠免疫和造血功能的影响.中药新药与临床药理,2003;14(14):174-6.
    11.李桂峰,康裕财,孙际佳,何建国.酵母多糖对赤眼鳟非特异性免疫机能的影响.中山大学学报(自然科学版),2003;42(4):55-58.
    12.林慧彬,林建强,林建群,路宁,衣秀义.山东产四种菟丝子免疫增强作用的比较研究.中西医结合学报,2003;1(1):51-3.
    13.石学魁,张晓莉,宋宝辉,等.五味消毒饮增强小鼠免疫功能的研究.细胞与分子免疫学杂志,2000;16(1):85.
    14.白东晓,姚德茂.迟发型超敏反应在肿瘤主动免疫治疗中的意义.现代肿瘤医学,2006;14(1):122-4.
    15.Krasteva M, Chabeau G, Claudy A, Nicolas JF. Physiopathology of contact dermatitis. J Eur Acad Dermatol Venereol, 1995; 5(2): 514.
    16.魏伟,沈玉先,徐叔云.淋巴细胞功能的测定.见:徐叔云,卞如濂,陈修主编.药理实验方法学(第3版),北京:人民卫生出版社,2002;1426-33.
    17.陈敏珠,魏伟,张泓.免疫抑制药和免疫增强药实验法.徐叔云,卞如濂,陈修主编.药理实验方法学(第3版),北京:人民卫生出版社,2002;1208-45.
    18.魏伟,沈玉先,徐叔云.淋巴细胞功能的测定.见:徐叔云,卞如濂,陈修主编.药理实验方法学(第3版),北京:人民卫生出版社,2002;1426-33.
    19.沈玉先,魏伟,徐叔云.细胞因子测定.见:徐叔云,卞如濂,陈修主编.药理实验方法学(第3版),北京:人民卫生出版社,2002;1438-55.
    20.Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.J Clin Invest, 1994; 94(2): 870-6.
    21.Hu ZQ, Toda M, Okubo S, Hara Y, Shimamura T. Mitogenic activity of (-)epigallocatechin gallate on B-cells and investigation of its structure-function relationship. Int J Immunopharmacol, 1992; 14 (8):1399-407.
    22.徐叔云,魏伟,梁君山.中药抗炎免疫药理的研究思路.药学进展,1992;16(2):65-70.
    23.徐叔云,梁君山,魏伟.我国抗炎免疫药理实验方法学研究现状.中国药理学通报,1992;2(2):81-4.
    24.Cohen N, Ader R, Bovbjerg D. Conditioned effects of cyclophosphamide. Enhancement of delayed-type hypersensitivity in the mouse. Annals of New York Academy of Sciences, 1987; 496: 553-60.
    25.李应全.影响免疫功能的化学药物.见李应全主编,临床免疫药理学(第1版),北京:中国协和医科大学出版社2003;253.
    26.马建国,于江.槐白皮对机体免疫功能影响的研究.山东中医杂志,2002;21(9):557-9.
    27.郑咏秋,魏伟,戴敏,汪倪萍.木瓜总苷抑制小鼠接触性超敏反应及对其胸腺T淋巴细胞亚型的调节作用.中国药理学通报,2004;20(9):1016-20.
    28 . Cappello F. Is CDla involved in antitumour immune responses duringcarcinogenesis?. British Journal of Cancer, 2004; 90(4): 938.
    29.张兰玲,孟济明,陈海生,韩星海.点腺过路黄正丁醇提取部分对小鼠免疫反应的影响.中药材,2002;25(12):888-90.
    30.马晓彤,王庭欣,蒋东升,赵文,秦淑贞,边庆荣,张俊刚.一种人参保健品功效作用的评价.卫生毒理学杂志,2003;17(1):61-2.
    31.Nowell PC. Phytohemagglutin in: An initiator of mitosis in culture of normal leukocytes. Cancer Res, 1960; 20(4): 462.
    32.郑永唐,昆龙.测定细胞存活和增殖的MTT方法的建立.免疫学杂志,1992;8(3):226-9.
    33.Mosmann TR. Cytokine patterns during the progression to AIDS. Science,1994; 265(5169): 193-4.
    34.Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Sionelli C, De Carli M, Tiri A, Ricci M. Accumulation of Th-2-Like helper T cells in the conjunctive of patients with vernal conjunctivitis. J Immunol, 1991; 146(4): 1169-74.
    35.Kidd P. Thl/Th2 balance:the hypothesis,its limitations,and implications for health and disease. Alterm Med Rev, 2003; 8(3): 223-46.
    36.Biedermann T,Mailhammer R,Mai A,Sander C, Ogilvie A, Brombacher F, Maier K, Levine AD, Rocken M. Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur J Immunol, 2001; 31(5): 1582-91.
    37.Wang LF, Sun CC, Wu JT, Lin RH. Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity. Clin Exp Allergy, 1999; 29(2): 71-9.
    38.何静,毕志刚,刘彦群.接触过敏与Th1/Th2淋巴细胞亚群平衡.国外医学皮肤性病学分册,2000;26(5):273.
    39.Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J ExpMed, 1991; 173(3): 673-9.
    40.Asada H, Linton J, Katz SI. Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4. J Invest Dermatol, 1997; 108(4): 406-11.
    41.王钦富,王永奇,郭连英,董妞妞,施广霞.过敏小鼠模型Th1/Th2漂移和纠正.中国免疫学杂志,2007;23(7):597-9.
    42.史川,盛晚香,宋韬.咪唑斯汀对小鼠变应性接触性皮炎的细胞免疫作用.武汉大学学报(医学版)2006;27(6):720-2.
    43.Nelson B H. IL-2, regulatory T cells, and tolerance. J Immunol, 2004; 172(7): 3983-8.
    44.Hanisch UK, Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Research Reviews, 1996; 2(1): 246-84.
    45.Brand CU, Yawalkar N, Hunziker T,Braathen LR. Human skin lumph derived from irritant and allergic contact dermatitis: interlerkin 10 is increased selectively in elicitation reactions. Dermatology, 1997; 194(1): 221.
    46.Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolooni G,Cavani A. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinoctyes. J lmmunol, 2000; 165(6): 3058-64.
    47.Nagai H, Ueda Y, Ochi T, Hirano Y, Tanaka H, Inagaki N, Kawada K. Difference of IL-4 in the onset of hapeten-induced contact hypersensitivity in BABL/c and C57BL/6 mice. Br J Pharmacol, 2000; 129(2): 299-306.
    48.Biedermann T, Mailhammer R, Mai A,Sander C, Ogilvie A, Brobacher F, Maier K, Levine AD, Rocken M. Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigens specific Th2 cells. Eur J Immunol, 2001; 31(5): 1582-91.
    49.Okazaki F, Kanzaki H, Fujii K, Arata J, Akiba H, Tsujii K, Iwatsuki K. Initial recruitment of interferon-gamma-producing CD8+ effector cells,followed by
    1.张玲玲,魏伟.木瓜苷对小鼠胶原性关节炎的预防作用及初步机制.中国药理学通报,2004;20(1):95-100.
    2.胡刚,段世明.伤害性感受的中枢生理学与药理学基础.张立生,刘小立主编.现代疼痛学(第一版),石家庄:河北科学技术出版社,2000;125-32.
    3.陈群,魏伟.木瓜苷对Ⅱ型胶原性关节炎大鼠滑膜细胞G蛋白偶联信号转导的作用及其机制.中国药理通讯,2003;20(3):46-8.
    4.戴敏,魏伟,汪倪萍,陈群.木瓜苷对大鼠佐剂性关节炎的治疗作用.中国药理学通报,2003;19(3):340-4.
    5.陈尹,魏伟,吴虹,唐丽琴,王晓玉,杨宇清.木瓜苷对佐剂性关节炎大鼠血清抗体水平的下调作用.中国药理学通报,2007;23(7):941-4.
    6.郑咏秋,魏伟,戴敏,汪倪萍.木瓜总苷抑制小鼠接触性超敏反应及对其胸腺T淋巴细胞亚型的调节作用.中国药理学通报,2004;20(9):1016-20.
    7.Zheng YQ , Wei W, Wang NP. Effects of Chaenomeles speciosa glucosides on cyclophosphamide potentiated contact hypersensitivity in mice. Chin J Pharmacol Toxicol, 2004; 18(6): 415-20.
    8.高崇凯,吴雁,王勇,颜杰,潘华新,曹柳英,梁瑞燕.白芍总苷粉针剂的抗炎、镇痛作用.中国新药药理与临床药理,2002;13(3):163-5.
    9.汪倪萍,魏伟.中药活性成分的抗炎免疫和镇痛作用.中国药理学通报,2003;19(4):366-70.
    10.朱蕾,魏伟.白芍总苷对胶原性关节炎及其免疫功能的影响.中国药学杂志,2007;42(20):1547-51.
    11.贾晓益,魏伟,郑咏秋,朱蕾.白芍总苷对胶原性关节炎滑膜组织中Bcl-2,Bax表达的影响.安徽医科大学学报,2006;41(2):143-6.
    12.朱蕾,魏伟,郑咏秋.白芍总苷对胶原性关节炎大鼠滑膜细胞的作用及机制.药学学报,2006;41(2):166-70.
    13.于慧敏,聂英坤,王璟璐.白芍总苷对膝骨性关节炎患者血清一氧化氮和白细胞介素-水平的影响.哈尔滨医科大学学报,2007;41(5):455-9.
    14.张泓,魏文树,陈敏珠.白芍总苷的免疫调节作用及机理.中国药理学与毒理学杂志,1990;4(3):190-3.
    15.李俊,梁君山,周爱武.白芍总苷对B淋巴细胞增殖和白介素1生成的调节作用.中国药理学与毒理学杂志,1994;8(1):53-4.
    16.魏伟,李晓辉,张洪泉.抗炎免疫药理学.北京:人民卫生出版社,2005;156-7.
    17.吴曙光,李晓辉,魏伟.抗炎免疫药理学进展(第2版).上海:第二军医大学出版社,2000;199-210.
    18.王晓玉,魏伟.抗炎免疫中药有效成分的药理学研究.中药新药与临床药理2006;17(4):314-6.
    19.周重楚,师海波,孙英莲.抗炎中草药研究进展.见:吴曙光主编,抗炎免疫药理学进展.上海:第二军医大学出版社,2000:199-210.
    20.Tao X, Lipsky PE. The Chinese antiinflammatory and immunosupPressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am, 2000; 26(1): 29-50.
    21.程晓明,王长征,刘卫东,钱桂生.雷公藤抑制致敏小鼠T细胞IL-5mRNA表达及GATA3活性.中华结核和呼吸杂志,2001;24(3):170-71.
    22.Zhou A, Scoggin S, Gaynor RB, Williams NS. IdentifiCation of NF-KappaB--regulated genes induced by TNFalpha utilizing exPression profiling and RNA interference. Oncogene, 2003; 22(13): 2054-64.
    23.薛建敏,徐永健,张珍祥,沈关心.雷公藤内酯醇对致敏大鼠淋巴细胞凋亡的影响.中华微生物学和免疫学杂志,2001;21(2):130-3.
    24.何为,杨业金,王辉丽,韩玲,汪少娟.雷公藤内酯醇对小鼠腹腔巨噬细胞杀伤活性的影响.现代免疫学,2004;24(2):116-116转123.
    25.杨春欣,马爱妞,董颖,王达妹,秦万章.雷公藤水溶性免疫抑制作用部位的筛选研究.中国中西医结合急救杂志,2001;8(5):268-70.
    26.林宗明,杨春欣,张永康,王国民,许迅辉,吕迁周,任豫申,董颖.去甲泽拉木醛与雷公藤多甙的免疫抑制作用比较.中华器官移植杂志,2004:25(1):42.
    27.魏伟,李晓辉,张洪泉.抗炎免疫药理学.北京:人民卫生出版,2005;156-7.
    28.Wang YP, Li XY, Song CQ, Hu ZB. Effect of astragaloside IV on T,B Lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin, 2002; 23(3): 263-6.
    29.Li SH, Chu Y. Anti-inflammatory effects of total saponins of Panax notoginseng. Acta Pharmacol Sin, 1999; 20(6): 551-4.
    30.陈剑鸿,王碧江,刘松青,王章阳.三七总皂苷对内毒素损伤血管内皮细胞炎症特性的影响.中国医院药学杂志,2004;24(3):l40-41.
    31.张佳红,王晋平,王慧娟.三七总皂苷调整类风湿关节炎免疫相关内环境失衡状态的临床研究.中国中西医结合杂志,2007;27(7):589-92.
    32.Cicero AF, Vitale G, Savino G, Arletti R. Panax notoginseng(Burk.) effects fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res, 2003; 17(2):174-8.
    33.张彩莲,呼彩莲,谢加利.三七总皂苷对家兔出血性坏死性肠炎的影响.科学技术与工程,2007;7(27):5759-62.
    34.韦颖,樊均明,潘丽萍.三七总甙对人肾成纤维细胞的影响.中国中西医结合杂志,2002;22(1):47-9.
    35.王宓,樊均明,刘欣颖,陈辉珍,唐嵘,刘先蓉.三七总皂苷对IL-1a诱导大鼠肾小管细胞转分化的影响.中国中西医结合杂志,2004;24(8):722-5.
    36.祝正明,孙建实,赵湘.三七总皂苷对大鼠肾小球系膜细胞增殖及细胞周期的影响.中国中西医结合肾病杂志,2007;8(8):471-2
    37.周小玲,李永伟,李逢春,杨志平.三七总皂苷对大鼠免疫功能影响的实验研究.广西医科大学学报,2001;18(3):360-2.
    38.YU S C, LI X Y. Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression inhippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol Sin, 2000; 21(10): 915-8.
    39.Smolinski AT,Pestka JJ.Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem Toxicol, 2003; 41(10): 1381-90.
    40.吴瑞琼,杨贵贞.人参皂苷通过海马增强大鼠脾脏免疫功能的研究.中国药理学通报,1992;8(3); 214-7.
    41.刘靖华,陈惠孙,胡德耀,刘良明.人参皂苷对创伤失血性休克免疫功能的调节作用.第三军医大学学报,2000;22(4):324-7.
    42.李卫平,陈敏珠.人参皂苷的免疫调节作用.安徽医科大学学报,1998;33(5):348-5.
    43.顾立学,燕春义,罗俊生.人参皂苷对小鼠G422胶质瘤免疫功能的影响.辽宁中医杂志,2007;34(4):523-4.
    44.李凌夫,王冬,张燕,王雅贤,杨宝华.人参皂苷Re对正常成人外周血LAK、NK细胞活性影响的实验研究.中医药信息,1996;13(3):54-5.
    45.解慧梅,黄会岭,胡格,刘易通,索占伟,张涛.人参皂苷Rbl和黄芪多糖对微血管内皮细胞分泌细胞因子的影响.中国兽医杂志,2007;43(11):50-2.
    46.Kodama Y, Xiaochuan L, Tsuchiya C, Ohizumi Y, Yoshida M, Nakahata N. Dual effect of saikogenin D: in vitro inhibition of prostaglandin E2 porduction and elevation of intracellular free Ca2+concentration in C6 rat glioma cells. Planta Med, 2003; 69(8): 765-7.
    47.Navarro P, Giner RM, Recio MC, Manez S, Cerda-Nicolas M, Rios JL. In vivo anti-inflammatory activity of saponins from Bupleurum rotundifolium. Life Sci, 2001; 68(10): 1199-206.
    48.Bermejo Benito P, Abad Martinez MJ, Silvan Sen AM, Sanz Gomez A, Fernandez Matellano L, Sanchez Contreras S, Diaz Lanza AM. In vivo and in vitroantiinflammatory activity of saikosaponins. Life Sci, 1998; 63(13): 1147-56.
    49.Just MJ, Recio MC, Giner RM, Cuellar MJ, Manez S, Bilia AR, Rios JL. Anti-inflammatory activity of unusual lupane saponins from Bupleurum fruticescens. Planta Med, 1998; 64(5): 404-7.
    50.汤文璐,李俊,徐叔云.丹皮总苷抗炎作用的研究.安徽医科大学学报,1999;34(1):11-3.
    51.徐叔云,汤文璐,李俊.丹皮总苷的抗炎免疫作用及部分机制研究.中国药理学通报,2002;18(6):656-60.
    52.王斌,葛志东,周爱武,陈敏珠.绞股蓝总皂苷体外对免疫细胞功能的影响.中药新药与临床药理,1999;10(1):36-7.
    53.林晓明,龙珠,李榴柏.绞股蓝皂苷及复方恢复老龄小鼠免疫功能和清除自由基作用.中国老年学杂志,1998;18(6):364-5.
    54.皮文霞,蔡宝昌,潘扬,钱继红.大孔树脂与活性炭富集山茱萸总苷的实验研究.中国中药杂志,2002;27(8):583-4.
    55.付桂香,李建民,周勇,赵世萍,山茱萸总苷抗炎免疫抑制作用及其机理的大鼠实验研究.中华微生物学和免疫学杂志,2007;27(4):316-20.
    56.郭丽丽,周勇,王旭丹,张丽,赵世萍,葛东宇.山茱萸分离提取物对脾淋巴细胞增殖的影响.北京中医药大学学报,2001;24(3):38-40.
    57.郭丽丽,周勇,王旭丹,张丽,赵世萍,葛东宇.山茱萸总苷抗类风湿关节炎免疫作用机理的初步研究.中国医学检验杂志,2002;20(3):197-9.
    58.Ju DW, Zheng QY, Cao X, Fang J, Wang HB. Esculentoside A inhibits tumor necrosis factor, nterleukin-1 and interleukin-6 production induced by lipopolysaccharide in mice.Pharmacology,1998; 56(4): 187-95.
    59.郑钦岳,王慧峰,郑向民,肖振宇,易杨华.商陆皂甙甲对兔滑膜细胞产生IL-1和TNF的影响.第二军医大学学报,2001;22(5):425-6.
    60.郑钦岳,方军,王洪斌.商陆皂苷甲对人外周血单核细胞产生肿瘤坏死因子的抑制作用.第二军医大学学报,1997;18(5):415-7.
    61.肖振宇,郑钦岳,张俊平.商陆皂苷甲对自身免疫综合征模型小鼠的疗效.第二军医大学学报,2003;24(10):1108-10.
    62.齐云,刘彬,宋杨,王敏,蔡润兰,谢忱,罗秀珍.甘草、桔梗总皂苷对体外磷脂酶A2活性的影响.中药药理与临床,2006;22(5):19-21.
    63.吕小华,吴铁,覃冬云.甘草酸对哮喘小鼠气道炎症及磷脂酶A2活性的影响.时珍国医国药,2007;18(10):2379-80.
    64.于辉,李春香,宫凌涛.甘草的药理作用概述.现代生物进展,2006;6(4):77-9.
    65.李斌霞,佟杰.甘草酸药理作用及机制的研究进展.数理医药学杂志,2007;20(2):228-31.
    66.吴虹,魏伟,宋礼华.栀子总苷的抗炎镇痛作用研究.中国中医药信息杂志,2006;13(7):31-3.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700